AbbVie to Present at Citi's 2024 Global Healthcare Conference
AbbVie (NYSE: ABBV) has announced its participation in Citi's 2024 Global Healthcare Conference scheduled for Tuesday, December 3, 2024. The company will be represented by three executive leaders: Scott T. Reents (CFO), Jeffrey R. Stewart (CCO), and Dr. Roopal Thakkar (EVP of R&D and CSO), who will present at 9:15 a.m. Central time.
The presentation will be accessible via live audio webcast through AbbVie's Investor Relations website, with an archived version available later that day.
AbbVie (NYSE: ABBV) ha annunciato la sua partecipazione alla Global Healthcare Conference 2024 di Citi, programmata per martedì 3 dicembre 2024. L'azienda sarà rappresentata da tre leader esecutivi: Scott T. Reents (CFO), Jeffrey R. Stewart (CCO) e Dr. Roopal Thakkar (EVP di R&D e CSO), che presenteranno alle 9:15 ora centrale.
La presentazione sarà accessibile tramite audio webcast in diretta attraverso il sito web delle Relazioni con Gli Investitori di AbbVie, con una versionearchiviata disponibile successivamente nello stesso giorno.
AbbVie (NYSE: ABBV) ha anunciado su participación en la Cumbre Global de Salud 2024 de Citi, programada para el martes 3 de diciembre de 2024. La empresa estará representada por tres líderes ejecutivos: Scott T. Reents (CFO), Jeffrey R. Stewart (CCO) y Dr. Roopal Thakkar (EVP de I+D y CSO), quienes presentarán a las 9:15 a.m., hora central.
La presentación estará accesible a través de un webcast de audio en vivo a través del sitio web de Relación con Inversores de AbbVie, con una versión archivada disponible más tarde ese mismo día.
AbbVie (NYSE: ABBV)는 2024년 12월 3일 화요일에 예정된 Citi의 2024 글로벌 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 회사는 Scott T. Reents (CFO), Jeffrey R. Stewart (CCO) 및 Dr. Roopal Thakkar (R&D EVP 및 CSO)라는 세 명의 경영진에 의해 대표됩니다. 이들은 중앙 표준시 기준으로 오전 9시 15분에 발표할 예정입니다.
발표는 AbbVie의 투자자 관계 웹사이트를 통해 실시간 오디오 웹캐스트로 접속할 수 있으며, 그날 나중에 아카이브된 버전도 제공될 예정입니다.
AbbVie (NYSE: ABBV) a annoncé sa participation à la Conférence mondiale sur la santé de Citi 2024, prévue pour le mardi 3 décembre 2024. L'entreprise sera représentée par trois dirigeants : Scott T. Reents (CFO), Jeffrey R. Stewart (CCO) et Dr. Roopal Thakkar (EVP R&D et CSO), qui présenteront à 9h15, heure centrale.
La présentation sera accessible via un webcast audio en direct sur le site Web des relations avec les investisseurs d'AbbVie, avec une version archivée disponible plus tard dans la journée.
AbbVie (NYSE: ABBV) hat seine Teilnahme an der Citi Global Healthcare Conference 2024 bekannt gegeben, die für Dienstag, den 3. Dezember 2024, geplant ist. Das Unternehmen wird durch drei Führungskräfte vertreten: Scott T. Reents (CFO), Jeffrey R. Stewart (CCO) und Dr. Roopal Thakkar (EVP für F&E und CSO), die um 9:15 Uhr zentraler Zeit präsentieren werden.
Die Präsentation wird über ein Live-Audio-Webcast auf der Investor-Relations-Website von AbbVie zugänglich sein, mit einer archivierten Version, die später am selben Tag verfügbar sein wird.
- None.
- None.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-citis-2024-global-healthcare-conference-302314669.html
SOURCE AbbVie
FAQ
When is AbbVie (ABBV) presenting at Citi's 2024 Global Healthcare Conference?
Who are the AbbVie executives presenting at Citi's 2024 Healthcare Conference?
How can investors watch AbbVie's (ABBV) presentation at Citi's 2024 Healthcare Conference?
